Comparison of Points of Departure for Health Risk Assessment Based on High-Throughput Screening Data

Salomon Sand; Frederick Parham; Christopher J. Portier; Raymond R. Tice; Daniel Krewski

Comparison of Points of Departure for Health Risk Assessment Based on High-Throughput Screening Data

Salomon Sand ^[4] ; Fred Parham ^[1] ; Christopher J. Portier ^[2] ; Raymond R. Tice ^[1] ; Daniel Krewski ^[3]
1. [1] National Institute of Environmental Health Sciences
  
  National Institute of Environmental Health Sciences
  
  Township of Durham, Estados Unidos
2. [2] Maastricht University
  
  Maastricht University
  
  Países Bajos
3. [3] University of Ottawa
  
  University of Ottawa
  
  Canadá
4. [4] 1 Department of Risk Benefit Assessment, National Food Agency, Uppsala, Sweden; 2 McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada
Mostrar afiliaciones +
Localización: Environmental health perspectives, ISSN 0091-6765, Vol. 125, Nº. 4, 2017, págs. 623-633
Idioma: inglés
DOI: 10.1289/EHP408
Enlaces
- Texto completo
Resumen
- The National Research Council’s vision for toxicity testing in the 21st century anticipates that points of departure (PODs) for establishing human exposure guidelines in future risk assessments will increasingly be based on in vitro high-throughput screening (HTS) data.
  
  The aim of this study was to compare different PODs for HTS data. Specifically, benchmark doses (BMDs) were compared to the signal-to-noise crossover dose (SNCD), which has been suggested as the lowest dose applicable as a POD.
  
  Hill models were fit to > 10,000 in vitro concentration–response curves, obtained for > 1,400 chemicals tested as part of the U.S. Tox21 Phase I effort. BMDs and lower confidence limits on the BMDs (BMDLs) corresponding to extra effects (i.e., changes in response relative to the maximum response) of 5%, 10%, 20%, 30%, and 40% were estimated for > 8,000 curves, along with BMDs and BMDLs corresponding to additional effects (i.e., absolute changes in response) of 5%, 10%, 15%, 20%, and 25%. The SNCD, defined as the dose where the ratio between the additional effect and the difference between the upper and lower bounds of the two-sided 90% confidence interval on absolute effect was 1, 0.67, and 0.5, respectively, was also calculated and compared with the BMDLs.
  
  The BMDL40, BMDL25, and BMDL18, defined in terms of extra effect, corresponded to the SNCD1.0, SNCD0.67, and SNCD0.5, respectively, at the median. Similarly, the BMDL25, BMDL17, and BMDL13, defined in terms of additional effect, corresponded to the SNCD1.0, SNCD0.67, and SNCD0.5, respectively, at the median.
  
  The SNCD may serve as a reference level that guides the determination of standardized BMDs for risk assessment based on HTS concentration–response data. The SNCD may also have application as a POD for low-dose extrapolation.
  
  Sand S, Parham F, Portier CJ, Tice RR, Krewski D. 2017. Comparison of points of departure for health risk assessment based on high-throughput screening data. Environ Health Perspect 125:623–633; http://dx.doi.org/10.1289/EHP408
Referencias bibliográficas
- Andersen, ME, Krewski, D. (2009). Toxicity testing in the 21st century: bringing the vision to life.. Toxicol Sci. 107. 324-330
- Barlow, S, Renwick, AG, Kleiner, J, Bridges, JW, Busk, L, Dybing, E. (2006). Risk assessment of substances that are both genotoxic and carcinogenic...
- Burgoon, LD, Zacharewski, TR. (2008). Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic...
- Crump, KS. (1984). A new method for determining allowable daily intakes.. Fundam Appl Toxicol. 4. 854-871
- Davis, JA, Gift, JS, Zhao, QJ. (2011). Introduction to benchmark dose methods and U.S. EPA’s benchmark dose software (BMDS) version 2.1.1.....
- Deveau, M, Chen, CP, Johanson, G, Krewski, D, Maier, A, Niven, KJ. (2015). The global landscape of occupational exposure limits—implementation...
- Dourson, M, Felter, S, Robinson, D. (1996). Evolution of science-based uncertainty factors in noncancer risk assessment.. Regul Toxicol Pharmacol....
- (2009). Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment.. EFSA J....
- Hsieh, JH, Sedykh, A, Huang, R, Xia, M, Tice, RR. (2015). A data analysis pipeline accounting for artifacts in Tox21 quantitative high-throughput...
- Inglese, J, Auld, DS, Jadhav, A, Johnson, RL, Simeonov, A, Yasgar, A. (2006). Quantitative high-throughput screening: a titration-based approach...
- Judson, RS, Kavlock, RJ, Setzer, RW, Hubal, EA, Martin, MT, Knudsen, TB. (2011). Estimating toxicity-related biological pathway altering doses...
- Krewski, D, Andersen, ME, Mantus, E, Zeise, L. (2009). Toxicity Testing in the 21st Century: implications for human health risk assessment.....
- Krewski, D, Westphal, M, Al-Zoughool, M, Croteau, MC, Andersen, ME. (2011). New directions in toxicity testing.. Annu Rev Public Health. 32....
- Murrell, JA, Portier, CJ, Morris, RW. (1998). Characterizing dose-response I: critical assessment of the benchmark dose concept.. Risk Anal....
- (2007). National Academies Press. Washington, DC.
- Sand, S, Ringblom, J, Håkansson, H, Öberg, M. (2012). The point of transition on the dose-effect curve as a reference point in the evaluation...
- Sand, S, Victorin, K, Filipsson, AF. (2008). The current state of knowledge on the use of the benchmark dose concept in risk assessment.....
- Sand, S, von Rosen, D, Victorin, K, Filipsson, AF. (2006). Identification of a critical dose level for risk assessment: developments in benchmark...
- Shockley, KR. (2015). Quantitative high-throughput screening data analysis: challenges and recent advances.. Drug Discov Today. 20. 296-300
- Slikker, W, Andersen, ME, Bogdanffy, MS, Bus, JS, Cohen, SD, Conolly, RB. (2004). Dose-dependent transitions in mechanisms of toxicity.. Toxicol...
- Slob, W, Pieters, MN. (1998). A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological...
- Thomas, RS, Black, MB, Li, L, Healy, E, Chu, TM, Bao, W. (2012). A comprehensive statistical analysis of predicting. Toxicol Sci. 128. 398-417
- Thomas, RS, Wesselkamper, SC, Wang, NC, Zhao, QJ, Petersen, DD, Lambert, JC. (2013). Temporal concordance between apical and transcriptional...
- (2005). U.S. EPA, Risk Assessment Forum. Washington, DC.
- (2012). PubChem’s BioAssay Database.. Nucleic Acids Res. 40. 400-412
- Wetmore, BA, Wambaugh, JF, Ferguson, SS, Sochaski, MA, Rotroff, DM, Freeman, K. (2012). Integration of dosimetry, exposure and high-throughput...
- (2004). Harmonization Document No. 1. IPCS Risk Assessment Terminology.. WHO. Geneva.
- Xia, M, Shahane, S, Huang, R, Titus, SA, Shum, E, Zhao, Y. (2011). Identification of quaternary ammonium compounds as potent inhibitors of...